パーキンソン病における全ゲノムスクリーニング:複数の遺伝子の証拠
W K Scott1, M A Nance, R L Watts
1Center for Human Genetics, Box 3445, Duke University Medical Center, Durham, NC 27710, USA.
JAMA
|November 17, 2001
まとめ
遺伝的リンク研究により,パーキンソン病 (PD) の早期発症に重要なパーキンソン遺伝子が特定されました. 多くの遺伝的要因が遅発のPDに寄与する可能性があり,この神経変性障害の複雑な遺伝的構造を強調しています.
科学分野:
- 遺伝学 遺伝学とは
- 神経学 神経学とは
- 医学研究 医学研究
背景:
- 異変性パーキンソン病 (PD) の遺伝的対環境的貢献は,依然として議論されている.
- いくつかの遺伝因子が稀なPD形態で知られているが,一般的なPDにおけるその役割は不明である.
研究 の 目的:
- イディオパシーパーキンソン病 (PD) に関連する遺伝的危険因子を特定する.
主な方法:
- 複数のPD診断を受けた174の家族で,包括的なゲノムスクリーニングが行われました.
- 遺伝的リンク分析は,870人の家族からのオッズ (lod) スコアのロガリズムを使用した.
- パラメトリックと非パラメトリックの分析は,1995年から2000年の間に収集されたデータで行われました.
主要な成果:
- 5つの染色体領域において,有意な関連性証拠が見つかりました.
- 染色体6のパーキン遺伝子は,早期発症のPDファミリー (MLOD=5.07,LOD=5.47) との強い関連性を示した.
- 遅発のPDでは染色体17q,8p,および5qとの結合が観察され,染色体9qはレボドーパに反応した症例と反応しない症例の両方で結合された.
結論:
- パーキンズ遺伝子は,早期発症のパーキンソン病の病原性において重要な役割を果たしています.
- 複数の遺伝的要因が,イディオパシー発症遅発のPDの発生に寄与している可能性が高い.
- これらの発見は,パーキンソン病の遺伝的異質性を強調しています.
関連する概念動画
01:43Incomplete Dominance
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...